A board to discuss future MS therapies in early stage (Phase I or II) trials.


Postby scorpion » Thu Jan 27, 2011 9:23 am

Receptos Initiates Clinical Trials for S1P1 Agonist Program, Aimed at Multiple Sclerosis <shortened url>
User avatar
Family Elder
Posts: 1323
Joined: Wed Nov 05, 2008 3:00 pm


Postby patientx » Thu Jan 27, 2011 3:22 pm

Sounds a lot like Gilenya.
User avatar
Family Elder
Posts: 1068
Joined: Wed Sep 10, 2008 2:00 pm

Postby dignan » Thu Jan 27, 2011 8:26 pm

Thanks for the info Scorpion. I agree patientx. I don't know if that's good or bad. On the bright side, it appears to be a worthwhile target. On the other hand, is there any reason to believe this will be better than gilenya?
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 2:00 pm

Postby rainer » Thu Jan 27, 2011 10:03 pm

If nothing else, maybe it will reduce the price gouging going on.
User avatar
Family Elder
Posts: 367
Joined: Thu Jan 17, 2008 3:00 pm

Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service